CHILI 4.0
Conference on Hybrid Imaging Live
Lectures
1 - NEW HORIZONS FOR HYBRID IMAGING
110:46CHILI 4.0
Total body PET/CT - key benefits and applications
Thomas Beyer, Vienna /AT
AI in multimodality hybrid imaging
Irène Buvat, Orsay /FR
Novel molecular imaging probes for oncologic imaging and what’s their translational potential
Andrew Scott
Round table discussion and Q&A
2 - ONCOLOGY 1: HYBRID IMAGING AS THE STANDARD OF CARE
104:47CHILI 4.0
PET/CT in lymphoma – the standard of clinical care
Marius Mayerhöfer
Lung carcinoma – the challenges in staging and therapy monitoring
Helmut Prosch
Why PET/CT in HNSCC?
Andrew Scarsbrook
Melanoma: imaging-based therapeutic management
Marcus Unterrainer
Round table discussion and Q&A
Symposium - LUNCH SYMPOSIUM (sponsored by Siemens Healthineers)
42:47CHILI 4.0
3 - ONCOLOGY 2: THE WORLD BEYOND FDG
105:27CHILI 4.0
Neuroendocrine tumors: therapeutic magagement with SSR-targeting tracers
Clemens Cyran
Prostate carcinoma: PSMA PET/CT in clinical decision guidance
Harun Ilhan
FAPI PET: the new FDG in solid tumors?
Frederik Giesel
FET PET/MRI in neuro-oncology
Jiří Ferda
Round table discussion and Q&A
Symposium - VALUE OF CONTRAST ENHANCED CT IN HYBRID IMAGING (sponsored by Bayer)
35:06Klaus Strobel
4 - INFECTION AND INFLAMMATION
93:47CHILI 4.0
Rheumatological diseases: the role of hybrid imaging
Mona-Elisabeth Revheim
Prothesis infection – from aortic replacements to endoprothesis
Michel Eisenblätter
Specific tracers in imaging of inflammation
José Vercher-Conejero
Hybrid imaging in COVID-19: What have we learned?
Manil Subesinghe
Round table discussion and Q&A